表紙
市場調查報告書

照護現場診斷的全球市場 - 成長率,趨勢及預測(2019年∼2024年)

Point-of-care Diagnostics Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品編碼 660545
出版日期 內容資訊 英文 114 Pages
商品交期: 2-3個工作天內
價格
照護現場診斷的全球市場 - 成長率,趨勢及預測(2019年∼2024年) Point-of-care Diagnostics Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年03月01日內容資訊: 英文 114 Pages
簡介

全球照護現場診斷市場上在預測期間內,預計將記錄9.8%的年複合成長率。肩負市場成長的主要原因之一,是開發中國家的慢性疾病及感染疾病的罹患率上升。由於糖尿病,風濕,以及癌症等慢性疾病的罹患率,老年人口的增加,久坐的生活方式習慣,不健康的飲食習慣,及環境要素等,各種理由而全球性增加著。譬如,每年3,800萬人以上的人因慢性疾病死亡。心血管疾病,年度有1,750萬人,佔慢性疾病死亡人數的大部分,其次為癌症(820萬人),呼吸疾病(400萬人),及糖尿病(150萬人)。這些疾病,佔慢性疾病死亡整體的82%。由於照護現場診斷,是為了實施檢驗從患者所在的地方收集樣品,由全世界各種患者廣泛接受,因為利用流體、晶片、奈米診斷,以非常短的時間可獲得結果。

本報告提供全球照護現場診斷市場調查,整體市場趨勢,各產品、地區的詳細趨勢,市場成長的影響要素分析,競爭情形,主要企業簡介等資訊彙整。

目錄

第1章 簡介

  • 調查的成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 開發中國家的慢性疾病及感染疾病的罹患率上升
    • 對新免疫測量技術的法規批准數量的增加
    • 技術的進步
    • 家用POC設備的使用增加
  • 市場阻礙因素
    • 大企業的產品回收刺激新加入廠商的意願
    • 嚴格的法規方針和償付問題
  • 波特的五力分析
    • 新加入廠商的威脅
    • 買主/買方議價能力
    • 供應商談判力
    • 替代產品的威脅
    • 產業內的競爭激烈度

第5章 市場區隔

  • 各產品
    • 葡萄糖監測套件
    • 心代謝監測套件
    • 妊娠、生殖能力檢測套組
    • 傳染病檢查套件
    • 膽固醇試驗帶
    • 血液檢測套組
    • 其他商品
  • 各終端用戶
    • 醫院/重症加護中心
    • 門診病人診療所
    • 研究所
    • 其他的終端用戶
  • 地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Abbott
    • Siemens AG
    • Beckman Coulter Inc.
    • Becton, Dickinson and Company
    • Instrumentation Laboratory
    • Johnson and Johnson
    • Nova Biomedical
    • Qiagen
    • F. Hoffmann-La Roche Ltd

第7章 市場機會及未來趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 55791

Market Overview

The point-of-care diagnostics market is expected to register a CAGR of 9.8%, over the forecast period. One of the major factors responsible for the growth of the market is the rising prevalence of chronic and infectious diseases in developing economies. The prevalence of chronic diseases, like diabetes, rheumatism, or cancer, is increasing globally, due to various reasons, such as an increase in geriatric population, sedentary lifestyles, unhealthy food habits, and environmental factors. For instance, chronic diseases kill more than 38 million people each year, globally. Cardiovascular diseases account for most chronic disease deaths, or 17.5 million people, annually, followed by cancers (8.2 million), respiratory diseases (4 million), and diabetes (1.5 million). The aforementioned diseases account for 82% of all the chronic disorder deaths. Point-of-care diagnostics is gaining wide acceptance by different patients across the world, as samples are collected from the patient's location for performing tests, and the results can be achieved in very less time, due to the use of micro fluids, chips, and nano diagnostics.

Factors, such as the increasing number of regulatory approvals for novel immunoassay techniques, technological advancements, and the rising usage of home-based POC devices, are expected to drive the market growth, over the forecasted period.

Scope of the Report

Point-of-care testing diagnostics have many advantages, which allows patient diagnoses at many places, such as in the physician's office, an ambulance, the home, the field, or in the hospital. The results of care are timely and offer rapid treatment to the patient.

Key Market Trends

Blood Glucose Testing is Expected to Hold Major Revenue Share in the Type of Products Segment

Blood glucose testing point-of-care diagnostics captured the largest share in 2018, due to the success of hand-held glucose meters, owing to their high adoption rate among the population across the world. Periodic monitoring of glucose level is of vital importance for diabetic patients, which has encouraged the adoption of POC among the diabetic patients in this segment. Other advantages associated with hand-held glucose meters are the portability and easy operability. Rising prevalence of diabetes across the world is expected to boost the segment growth in the future.

North America Dominates the Market and is Expected to do Same in the Forecast Period

Currently, North America dominates the market for point-of care-diagnostics, and is expected to continue its stronghold for a few more years. In the North America region, the United States holds the largest market share. This can be majorly attributed due to the growing geriatric population base in the country, as well as the factors, such as the increasing prevalence of diseases and the favorable government regulations and initiatives undertaken for the development of healthcare infrastructure.

Competitive Landscape

The point-of-care diagnostics market is moderately competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. With rising prevalnce of diseases and increasing number of aging population, other players are also expcted to enter into the market. Some of the major players of the market are Abbott, Siemens AG, Becton, Dickinson and Company, Johnson and Johnson, and F. Hoffmann-La Roche Ltd, among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Chronic and Infectious Diseases in Developing Economies
    • 4.2.2 Increasing Number of Regulatory Approvals for Novel Immunoassay Techniques
    • 4.2.3 Technological Advancements
    • 4.2.4 Rising Usage of Home-based POC Devices
  • 4.3 Market Restraints
    • 4.3.1 Product Recalls by Major Players Demotivate New Entrants
    • 4.3.2 Stringent Regulatory Policies and Reimbursement Issues
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Glucose Monitoring Kit
    • 5.1.2 Cardio-metabolic Monitoring Kit
    • 5.1.3 Pregnancy and Fertility Testing Kit
    • 5.1.4 Infectious Disease Testing Kit
    • 5.1.5 Cholesterol Test Strip
    • 5.1.6 Hematology Testing Kit
    • 5.1.7 Other Products
  • 5.2 By End User
    • 5.2.1 Hospital/Critical Care Setting
    • 5.2.2 Ambulatory Care Setting
    • 5.2.3 Research Laboratory
    • 5.2.4 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East & Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East & Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott
    • 6.1.2 Siemens AG
    • 6.1.3 Beckman Coulter Inc.
    • 6.1.4 Becton, Dickinson and Company
    • 6.1.5 Instrumentation Laboratory
    • 6.1.6 Johnson and Johnson
    • 6.1.7 Nova Biomedical
    • 6.1.8 Qiagen
    • 6.1.9 F. Hoffmann-La Roche Ltd

7 MARKET OPPORTUNITIES AND FUTURE TRENDS